Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-08

Clinical Trial Update: How Different Beta-2 Receptor Genotypes Affect an Asthmatic's Response to Regular Salmeterol Treatment [NA]

View source ↗

Summary

A completed clinical trial assesses how beta-2 receptor genotypes affect asthmatics' response to regular salmeterol treatment. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Salmeterol (salmeterol)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Asthma | NA | Status: COMPLETED | Results posted: 2014-08-08